"Patients diagnosed with headache may benefit from concurrent behavioral health evaluation and treatment," researchers said.

The Food and Drug Administration has approved Journavx (suzetrigine) for the treatment of moderate to severe acute pain in adults.

About 80 million Americans fill prescriptions each year for medications to treat new instances of moderate to severe pain, ...

Popular singer Sonu Nigam recently experienced severe pain due to a muscle spasm before performing in Pune. Despite the pain, ...

Sonu Nigam recently suffered terrible pain at his concert in Pune. With the help of his team, he was escorted from the stage.

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in ...

Sonu Nigam’s incredible performance at Rashtrapati Bhavan, despite battling severe back pain, is a story of resilience and ...

Three in ten women are afraid of the pain of placing an IUD and have, therefore, avoided this type of contraception in the ...

Punishing 25% levies on imports from America’s closest neighbors were due to come into force at 12:01 a.m. ET Tuesday, but ...

When seven-year-old Ruby McKernan started suffering from headaches, her parents Gary and Kelly initially thought she was just ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

The encouraging result comes just days after the US FDA approved Vertex Pharma's non-opioid painkiller Journavx (suzetrigine) ...